Cargando…
Novel acute hypersensitivity pneumonitis model induced by airway mycosis and high dose lipopolysaccharide
BACKGROUND: Inhalation of fungal spores is a strong risk factor for severe asthma and experimentally leads to development of airway mycosis and asthma-like disease in mice. However, in addition to fungal spores, humans are simultaneously exposed to other inflammatory agents such as lipopolysaccharid...
Autores principales: | Zeng, Yuying, Zhang, Yun, Huang, Xinyan, Song, Lizhen, Polsky, Katherine, Wu, Yifan, Kheradmand, Farrah, Guo, Yubiao, Green, Linda K., Corry, David B., Knight, John M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503997/ https://www.ncbi.nlm.nih.gov/pubmed/34629055 http://dx.doi.org/10.1186/s12931-021-01850-5 |
Ejemplares similares
-
Airway Mycosis and the Regulation of Type 2 Immunity
por: Knight, John Morgan, et al.
Publicado: (2020) -
Benefits of antifungal therapy in asthma patients with airway mycosis: A retrospective cohort analysis
por: Li, Evan, et al.
Publicado: (2018) -
Hypersensitivity pneumonitis
por: Lacasse, Yves, et al.
Publicado: (2006) -
Chronic hypersensitivity pneumonitis
por: Pereira, Carlos AC, et al.
Publicado: (2016) -
Experimental hypersensitivity pneumonitis: role of MCP-1()
por: Schuyler, Mark, et al.
Publicado: (2003)